Search results

Journal Article (143)

  1. Journal Article
    Grünhagen, H. H.; Eibl, H.; Krebs, G.; Reiter, P.: Phospholipid and fatty acid composition of tetrodotoxin receptor-rich membrane fragments from Electrophorus electricus. Biochimica et Biophysica Acta 732 (3), pp. 675 - 682 (1983)
  2. Journal Article
    Siminovitch, D. J.; Jeffrey, K. R.; Eibl, H.: A comparison of the headgroup conformation and dynamics in synthetic analogs of dipalmitoylphosphatidylcholine. Biochimica et Biophysica Acta 727 (1), pp. 122 - 134 (1983)
  3. Journal Article
    Stümpel, J.; Eibl, H.; Niksch, A.: X-ray analysis and calorimetry on phosphatidylcholine model membranes. The influence of length and position of acyl chains upon structure and phase behaviour. Biochimica et Biophysica Acta 727 (2), pp. 246 - 254 (1983)

Book Chapter (2)

  1. Book Chapter
    Berger, M. R.; Tsoneva, I.; Konstantinov, S. M.; Eibl, H.: Induction of apoptosis by erucylphospho-N,N,N-trimethylammonium is associated with changes in signal molecule expression and location. In: Apoptosis: From signaling pathways to therapeutic tools, pp. 307 - 310. New York Acad. Ssc., New York (2003)
  2. Book Chapter
    Eibl, H.; Unger, C.: Phosholipide als Antitumormittel. Möglichkeiten einer selektiven Therapie. In: Die Zellmembran als Angriffspunkt der Tumortherapie (Ed. Unger, C.). Zuckerschwerdt, München (1987)

Conference Paper (17)

  1. Conference Paper
    Papa, V.; Tazzari, P.; Chiarini, F.; Ricci, F.; Martinelli, G.; Bontadini, A.; McCubrey, J.; Lindner, L. H.; Eibl, H.; Martelli, A. M.: Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, induces cell cycle arrest, apoptosis, and synergizes with chemotherapeutic drugs in acute myelogenous leukemia cells-a novel therapeutic approach for leukemia. 50th Annual Meeting of the American- Society-of-Hematology, San Francisco, December 06, 2008 - December 09, 2008. Blood 112 (11), p. 480 - 480 (2008)
  2. Conference Paper
    Henke, G.; Lindner, L. H.; Vogeser, M.; Eibl, H.; Woerner, J.; Bamberg, M.; Belka, C.; Jendrossek, V.: Pharmaceutical kinetics and bio-availability of Erufosine in the nude-mouse model. Strahlentherapie und Onkologie 184 (Suppl. 1), p. 122 - 122 (2008)
  3. Conference Paper
    Ruebel, A.; Handrick, R.; Eibl, H.; Belka, C.; Jendrossek, V.: The combined effect of membrane operative apoptosis modulator and radiation therapy is dependent form mitochondrial cell death path. Strahlentherapie und Onkologie 184 (Suppl. 1), p. 50 - 50 (2008)
  4. Conference Paper
    Erdlenbruch, B.; Preusse, A.; Huelper, P.; Kugler, W.; Eibl, H.; Lakomek, M.: Increased transfer of antibodiesto the CNS using BBB opening with 1-O-pentylglycerol and 2-O-hexyldiglycerol: Visualization of drug transfer using in vivo optical imaging. Neuro-Oncology 8 (4), p. 328 - 328 (2006)
  5. Conference Paper
    Ruebel, A.; Handrick, R.; Eibl, H.; Budach, W.; Belka, C.; Jendrossek, V.: Membrane-effective apoptosis modulators improve the radiation effect on cell lines of malignant gliomas in vitro: Influence on cell death- and survival signal paths. Strahlentherapie und Onkologie 182 (Suppl. 1), p. 85 - 85 (2006)
  6. Conference Paper
    Ruebel, A.; Handrick, R.; Eibl, H.; Budach, W.; Belka, C.; Jendrossek, V.: Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of PKB/Akt-mediated survival signalling. Radiotherapy and Oncology 78 (Suppl. 1), p. S49 - S49 (2006)
  7. Conference Paper
    Handrick, R.; Rudner, J.; Mueller, I.; Eibl, H.; Belka, C.; Jendrossek, V.: Importance of sub-cellular localisation of Bcl-2 for the protective effect against erucylphosphocholin-induced apoptosis. Strahlentherapie und Onkologie 181 (Suppl. 1), p. 104 - 104 (2005)
  8. Conference Paper
    Ruebel, A.; Handrick, R.; Eibl, H.; Belka, C.; Jendrossek, V.: Influence of erucylphosphocholin on the sensitivity of glioblastoma cell lines opposite radiation-induced apoptosis. Strahlentherapie und Onkologie 181 (Suppl. 1), pp. 103 - 104 (2005)
  9. Conference Paper
    Jendrossek, V.; Ruebel, A.; Handrick, R.; Eibl, H.; Budach, W.; Belka, C.: Apoptosis signaling as a target for modulation of radiation response. European Journal of Cell Biology 84 (Suppl. 55), p. 116 - 116 (2005)
  10. Conference Paper
    Eibl, H.: Alkylphosphocholines - A new class of antitumor drugs. Journal of the American Chemists Society 65 (4), p. 517 - 517 (1988)
  11. Conference Paper
    Berger, M. R.; Schmahl, D.; Unger, C.; Eibl, H. J.: Antineoplastic activity of alkylphosphocholine derivates in methylnitrosourea (MNU)-induced rat mammary-carcinoma. Proceedings of the American Association for Cancer 29, p. 330 - 330 (1988)
  12. Conference Paper
    Eibl, H.; Unger, C.: Phospholipids-selective drugs in cancer-therapy. Proceedings of the American Association for Cancer 29, p. 358 - 358 (1988)
  13. Conference Paper
    Schuff-Werner, P.; Unger, C.; Nagel, G. A.; Eibl, H.: Cryopreservation of mononuclear cells by 1-O-methyl-rac-glycerol and 1,2 propanediol. Cryobiology 85 (9), p. 319 - 319 (1986)
  14. Conference Paper
    Cantor, M.; Zakim, D.; Eibl, H. J.: Influence of phospholipids on the function of glucuronosyl transferase (GT). Hepatology 6 (5), p. 1187 - 1187 (1986)
  15. Conference Paper
    Schick, H. D.; Berdel, W. E.; Fromm, M.; Fink, U.; Jehn, U.; Ulm, K.; Reichert, A.; Eibl, H.; Rastetter, J.: The effect of ether-lipid derivatives on tritiated-zhymidine uptake and trypan blue-dye exclusion invitro of nonneoplastic bone-marrow cells and leukemic-cells from humans. Blut 53 (3), p. 196 - 196 (1986)
Go to Editor View